Short Interest in Halberd Co. (OTCMKTS:HALB) Rises By 22.0%

Halberd Co. (OTCMKTS:HALBGet Free Report) was the target of a significant growth in short interest during the month of October. As of October 15th, there was short interest totalling 68,700 shares, a growth of 22.0% from the September 30th total of 56,300 shares. Based on an average trading volume of 2,643,800 shares, the short-interest ratio is currently 0.0 days.

Halberd Stock Performance

Shares of Halberd stock remained flat at $0.00 during trading on Wednesday. 335,700 shares of the stock traded hands, compared to its average volume of 1,169,286. The company has a 50 day moving average of $0.01 and a two-hundred day moving average of $0.01. Halberd has a fifty-two week low of $0.00 and a fifty-two week high of $0.01.

Halberd Company Profile

(Get Free Report)

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

Featured Articles

Receive News & Ratings for Halberd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halberd and related companies with MarketBeat.com's FREE daily email newsletter.